drugset / Trial / NCT06242652
A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect and safety of 608 in patients with AS.
Timeline
- Start
- 2024-03-19
- Primary completion
- 2025-02-27
- Completion
- 2025-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 608 | Unknown | — | Subcutaneous |
| Comparator | Adalimumab | Monoclonal antibody | — | Subcutaneous |